Category: updates
2022 AGM and Scientific Conference
Cardiovascular disease implicated in rapid glaucoma progression
Meta-analysis finds comparable safety profiles between bevacizumab and ranibizumab
Using data from 5 multicenter randomized trials, investigators compared the risk of systemic adverse events (SAE) associated with ranibizumab and…
Low-cost ziv-aflibercept appears safe for intraocular administration
Telemedicine screening confirms acute ROP is typically symmetrical
Timing of IOL repositioning surgery significantly impacts refractive outcomes
This large retrospective study analyzed the incidence and appropriate timing of repositioning surgery to correct misalignment of toric IOLs. Study…
Injected mitomycin C offers advantages over standard application
This multicenter, randomized clinical trial compared 2 methods for applying mitomycin C (MMC) in eyes undergoing trabeculectomy. Study design Investigators…
Panel issues first U.S. guidelines for childhood retinoblastoma screening
2022 AGM and Scientific Conference
Cardiovascular disease implicated in rapid glaucoma progression
Meta-analysis finds comparable safety profiles between bevacizumab and ranibizumab
Using data from 5 multicenter randomized trials, investigators compared the risk of systemic adverse events (SAE) associated with ranibizumab and…
Low-cost ziv-aflibercept appears safe for intraocular administration
Telemedicine screening confirms acute ROP is typically symmetrical
Timing of IOL repositioning surgery significantly impacts refractive outcomes
This large retrospective study analyzed the incidence and appropriate timing of repositioning surgery to correct misalignment of toric IOLs. Study…
Injected mitomycin C offers advantages over standard application
This multicenter, randomized clinical trial compared 2 methods for applying mitomycin C (MMC) in eyes undergoing trabeculectomy. Study design Investigators…